Interim results from a phase I trial of SL-801: A novel XPO-1 inhibitor, in patients with advanced solid tumors
Bauer, T M, Barve, M, Chiorean, E G, Lorusso, P, Courtney, K, Qi, D, Olguin, A, Bullington, J, Sardone, M, Dunn, V, Shemesh, S, Chen, J, Brooks, C, Wang, J
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
FRI0623-HPR Body Awareness in Persons Diagnosed with Rheumatoid Arthritis
Lööf, H., Johansson, U.-B., Welin Henriksson, E., Lindblad, S., Bullington, J.
Published in Annals of the rheumatic diseases (01.06.2015)
Published in Annals of the rheumatic diseases (01.06.2015)
Get full text
Journal Article
Results of phase II trial of SL-701, a novel immunotherapy targeting IL-13Ra2, EphA2, and survivin, in adults with second-line recurrent glioblastoma (GBM)
Peereboom, D., Nabors, L.B., Kumthekar, P., Badruddoja, M., Fink, K., Lieberman, F., Phuphanich, S., Dunbar, E., Walbert, T., Schiff, D., Tran, D.D., Ashby, L.S., Butowski, N., Iwamoto, F., Lindsay, R., Bullington, J., Schulder, M., Sherman, J., Brooks, C., Reardon, D.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
564P Updated results of a phase I study of Felezonexor (SL-801), a novel XPO-1 reversible inhibitor, in patients with relapsed/refractory solid tumours
Wang, J.S., Barve, M.A., Chiorean, E.G., LoRusso, P., Courtney, K.D., Qi, D., Bullington, J., Sardone, M., Chen, J., Brooks, C., Hoberman, M., Mughal, T.I., Bauer, T.M.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
466PInterim results from trial of SL-801, a novel XPO-1 inhibitor, in patients with advanced solid tumours
Wang, J, Barve, M, Chiorean, E, LoRusso, P, Courtney, K, Qi, D, Bullington, J, Sardone, M, Chen, J, Brooks, C, Shemesh, S, Bauer, T M
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
466P - Interim results from trial of SL-801, a novel XPO-1 inhibitor, in patients with advanced solid tumours
Wang, J., Barve, M., Chiorean, E., LoRusso, P., Courtney, K., Qi, D., Bullington, J., Sardone, M., Chen, J., Brooks, C., Shemesh, S., Bauer, T.M.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Interim results from trial of SL-801, a novel XPO-1 inhibitor, in patients with advanced solid tumours
Wang, J., Barve, M., Chiorean, E., LoRusso, P., Courtney, K., Qi, D., Bullington, J., Sardone, M., Chen, J., Brooks, C., Shemesh, S., Bauer, T.M.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Ongoing phase 1 trial of SL-801, a novel XPO-1 inhibitor, in patients with advanced solid tumors; Interim results
Wang, J., Nemunaitis, J., Chiorean, G., Lorusso, P., Courtney, K., Olguin, A., Bullington, J., Shemesh, S., Chen, J., Brooks, C., Bauer, T.M.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
428PInterim results from a phase I trial of SL-801: A novel XPO-1 inhibitor, in patients with advanced solid tumors
Bauer, T M, Barve, M, Chiorean, E G, Lorusso, P, Courtney, K, Qi, D, Olguin, A, Bullington, J, Sardone, M, Dunn, V, Shemesh, S, Chen, J, Brooks, C, Wang, J
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
The fuzzy concept of 'holistic care': a critical examination
Bullington, Jennifer, Fagerberg, Ingegerd
Published in Scandinavian journal of caring sciences (01.09.2013)
Published in Scandinavian journal of caring sciences (01.09.2013)
Get full text
Journal Article
373OResults of phase II trial of SL-701, a novel immunotherapy targeting IL-13Ra2, EphA2, and survivin, in adults with second-line recurrent glioblastoma (GBM)
Peereboom, D, Nabors, L B, Kumthekar, P, Badruddoja, M, Fink, K, Lieberman, F, Phuphanich, S, Dunbar, E, Walbert, T, Schiff, D, Tran, D D, Ashby, L S, Butowski, N, Iwamoto, F, Lindsay, R, Bullington, J, Schulder, M, Sherman, J, Brooks, C, Reardon, D
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Body awareness in persons diagnosed with rheumatoid arthritis
Lööf, Helena, Johansson, Unn-Britt, Welin Henriksson, Elisabet, Lindblad, Staffan, Bullington, Jennifer
Published in ANNALS OF THE RHEUMATIC DISEASES (2015)
Published in ANNALS OF THE RHEUMATIC DISEASES (2015)
Get full text
Journal Article
Conference Proceeding
The development of novel and selective p56lck tyrosine kinase inhibitors
BULLINGTON, J. L, CAMERON, J. C, DAVIS, J. E, DODD, J. H, HARRIS, C. A, HENRY, J. R, PELLEGRINO-GENSEY, J. L, RUPERT, K. C, SIEKIERKA, J. J
Published in Bioorganic & medicinal chemistry letters (22.09.1998)
Published in Bioorganic & medicinal chemistry letters (22.09.1998)
Get full text
Journal Article
Meaning out of chaos: a way to understand chronic pain
Bullington, Jennifer, Nordemar, Rolf, Nordemar, Kristina, Sjöström-Flanagan, Charlotte
Published in Scandinavian journal of caring sciences (01.12.2003)
Published in Scandinavian journal of caring sciences (01.12.2003)
Get full text
Journal Article
From Health to Disease: A New Approach to Study the Emergence of Psychosomatic Symptoms
Get full text
Journal Article
Publication